Please join The University of Sydney Nano Institute for our next Distinguished Lecture on 'Engineering in Precision Medicine' by Professor Ali Khademhosseini, CEO and Founding Director at the Terasaki Institute for Biomedical Innovation.

About the Lecture

Engineered materials that integrate advances in polymer chemistry, nanotechnology, and biological sciences have the potential to create powerful medical therapies. Prof. Khademhosseini's research is interested in developing ‘personalized’ solutions that utilize micro- and nanoscale technologies to enable a range of therapies for organ failure, cardiovascular disease and cancer. The lecture will be moderated by Sydney Nano member, Professor Fariba Dehghani.

Event details:

• Wednesday 25 August 2021
• 10.00am - 11.00am, AEST
• Online, free event.
• Zoom ID: 811 7744 9244, Password: Sydney
• Join here: https://uni-sydney.zoom.us/j/81177449244?pwd=M2NaRXRYdkd4VFFwZmFFZFNUY1hHdz09 (Zoom help below)

Please be sure to RSVP to the event by 24 August.

___________________

About the Speaker

Ali Khademhosseini is currently the CEO and Founding Director at the Terasaki Institute for Biomedical Innovation. Previously, he was a Professor of Bioengineering, Chemical Engineering and Radiology at the University of California-Los Angeles (UCLA). He joined UCLA as the Levi Knight Chair in November 2017 from Harvard University where he was Professor at Harvard Medical School (HMS) and faculty at the Harvard-MIT’s Division of Health Sciences and Technology (HST), Brigham and Women’s Hospital (BWH) and as well as associate faculty at the Wyss Institute for Biologically Inspired Engineering.

At Harvard University, he directed the Biomaterials Innovation Research Center (BIRC) a leading initiative in making engineered biomedical materials. Dr. Khademhosseini is an Associate Editor for ACS Nano. He served as the Research Highlights editor for Lab on a Chip. He is a fellow of the American Institute of Medical and Biological Engineering (AIMBE), Biomedical Engineering Society (BMES), Royal Society of Chemistry (RSC), Biomaterials Science and Engineering (FBSE), Materials Research Society (MRS), NANOSMAT Society, and American Association for the Advancement of Science (AAAS). He is also the recipient of the Mustafa Prize ($500,000 prize) and is a member of the International Academy of Medical and Biological Engineering, Royal Society of Canada and Canadian Academy of Engineering, and National Academy of Inventors.

___________________

Abstract

Engineered materials that integrate advances in polymer chemistry, nanotechnology, and biological sciences have the potential to create powerful medical therapies. Dr. Khademhosseini is interested in developing ‘personalized’ solutions that utilize micro- and nanoscale technologies to enable a range of therapies for organ failure, cardiovascular disease and cancer. In enabling this vision, he works closely with clinicians (including interventional radiologists, cardiologists and surgeons). For example, he has developed numerous techniques in controlling the behavior of patient-derived cells to engineer artificial tissues and cell-based therapies.His group also aims to engineer tissue regenerative therapeutics using water-containing polymer networks called hydrogels that can regulate cell behavior.

Specifically, he has developed photo-cross-linkable hybrid hydrogels that combine natural biomolecules with nanoparticles to regulate the chemical, biological, mechanical and electrical properties of gels.These functional scaffolds induce the differentiation of stem cells to desired cell types and direct the formation of vascularized heart or bone tissues. Since tissue function is highly dependent on architecture, he has also used microfabrication methods, such as microfluidics, photolithography, bioprinting, and molding, to regulate the architecture of these materials. He has employed these strategies to generate miniaturized tissues. To create tissue complexity, he has also developed directed assembly techniques to compile small tissue modules into larger constructs. It is anticipated that such approaches will lead to the development of next-generation regenerative therapeutics and biomedical devices.

___________________

Have questions about the event?

Please contact Deputy Director Member Engagement, Dr Omid Kavehei (omid.kavehei@sydney.edu.au), with any questions about the lecture content, and sydneynano.admin@sydney.edu.au with any questions about the event.

Zoom help

Need help using Zoom? Visit the Zoom Help Center: https://support.zoom.us

• Join from PC, Mac, Linux, iOS or Android: https://uni-sydney.zoom.us/j/83242658497?pwd=MFd3MDJYdGkzUTBZTGhaWG81S015Zz09 Password: Sydney
• Or iPhone one-tap : Australia: +61861193900,,83242658497# or +61871501149,,83242658497#
• Or Telephone: Dial(for higher quality, dial a number based on your current location): Australia: +61 8 6119 3900, Meeting ID: 832 4265 8497, Password: 436056
• International numbers available: https://uni-sydney.zoom.us/u/khCMXoPVC